NIDA Research Monograph, Number 28 [Printed in 1981]
If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able
to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.
This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.
Download Monograph28.pdf - Narcotic Antagonists: Naltrexone Pharmacochemistry and Sustained-Release Preparations (2.5 MB)
Table of Contents
Foreword-----v
The Editors
PART I INTRODUCTION AND OVERVIEW
Historical Perspective on the Chemistry and Development of Naltrexone-----3
Sydney Archer
Treatment of Heroin-Dependent Persons With Antagonists: Current Status-----11
Pierre Renault
PART II ANALYTICAL METHODS
An Electron-Capture Gas Chromatographic Assay for Naltrexone in Biological Fluids-----25
R. H. Reuning, S. B. Ashcraft, and B. E. Morrison
Quantitative Determination of Naltrexone, 6 β-Naltrexol and 2-Hydroxy-3-methoxy-6β-naltrexol (HMN) in Human Plasma, Red Blood Cells, Saliva and Urine by Gas Liquid Chromatography-----36
Karl Verebey
Analytical Methods for Quantitative and Qualitative Analysis of Naltrexone and Metabolites in Biological Fluids-----52
Monroe E. Wall and Dolores R. Brine
PART III PHARMACOLOGY
Background on Animal Testing in the Drug Delivery Systems Program-----69
William L. Dewey
Pharmacological Evaluation of Narcotic Antagonist Delivery Systems in Rhesus Monkeys-----77
Stephen E. Harrigan and David A. Dawns
A Comparative Study of the Oral, Intravenous, and Subcutaneous Administration of 3H Naltrexone to Normal Male Volunteers-----93
Mario Perez-Reyes and Monroe E. Wall
PART IV METABOLISM
The Metabolism of Naltrexone in Man-----105
Monroe E. Wall, Dolores R. Brine, and Mario Perez-Reyes
Current Status of Preclinical Research on Disposition, Pharmacokinetics, and Metabolism of Naltrexone-----132
Anand L. Misra
The Clinical Pharmacology of Naltrexone: Pharmacology and Pharmacodynamics-----147
Karl Verebey
PART V PHARMACOKINETICS
Overview of Human Pharmacokinetics of Naltrexone-----161
Vojtech Licko
Pharmacokinetic Quantitation of Naltrexone Release From Several Sustained-Release Delivery Systems-----172
R. H. Reuning, S.H.T. Liao, and A.E. Staubus
PART VI SUSTAINED-RELEASE SYSTEMS
A Review of Parenteral Sustained-Release Naltrexone Systems-----187
James L. Olsen and Fred A. Kincl
Development of Drug Delivery Systems for use in Treatment of Narcotic Addiction-----194
A. Carl Sharon and Donald L. Wise
Use of Synthetic Polypeptides in the Preparation of Biodegradable Delivery Systems for Narcotic Antagonists-----214
Kenneth R. Sidman, Arthur D. Schwope, William D. Steber, and Stephen E. Rudolph
Biodegradable Drug Delivery Systems Based on Aliphatic Polyesters: Application to Contraceptives and Narcotic Antagonists-----232
Colin G. Pitt, Thomas A. Marks, and Anton Schindler
An Improved Long-Acting Delivery System for Narcotic Antagonists-----254
Anand L. Misra and Ronald B. Pontani
Solid Solutions as Long-Acting Naltrexone Delivery Systems-----265
James L. Olsen
Participants in Technical Review-----272
List of Monographs-----274
|
